Digestive Diseases and Sciences

, Volume 55, Issue 6, pp 1503–1505

Probing the Occult: Testing for Blood in the Stools



  1. 1.
    Sawhney MS, McDougall H, Nelson DB, Bond JH. Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci. 2010. doi:10.1007/s10620-010-1150-4.
  2. 2.
    Van Rossum LGV, Van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterol. 2008;135:82–90.CrossRefGoogle Scholar
  3. 3.
    Hol L, Van Leerdam ME, Van Ballegooijen M, et al. Screening for colorectal cancer: randomized trial comparing guaiac-based and immunochemical fecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62–68.CrossRefPubMedGoogle Scholar
  4. 4.
    Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104:739–750.CrossRefPubMedGoogle Scholar
  5. 5.
    Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal cancer and the American College of Radiology. Gastroenterol. 2008;134:1570–1595.CrossRefGoogle Scholar
  6. 6.
    Chung DC. Stool DNA testing and colon cancer prevention. AGA Perspectives. 2009;7(12):12–13.Google Scholar
  7. 7.
    McCarthy DM. Occult GI bleeding in NSAID users—the base of the iceberg (editorial). Clinical Gastroenterol & Hepatol. 2005;3:1071–1074.CrossRefGoogle Scholar
  8. 8.
    Chan FKL, Ching JYL, Hung LCT, et al. Clopidogrel versus aspirin and omeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238–244.CrossRefPubMedGoogle Scholar
  9. 9.
    Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549.CrossRefPubMedGoogle Scholar
  10. 10.
    Atkin WS. UK Flexible Sigmoidoscopy Screening trial investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicenter randomised trial. Lancet. 2002;359:1291–1300.CrossRefGoogle Scholar
  11. 11.
    Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomized controlled trial. BMJ. 2009;338(7707):b1846–b1852.CrossRefPubMedGoogle Scholar
  12. 12.
    Ransohoff DF. Lessons from the UK sigmoidoscopy screening trial. Lancet. 2002;359:1266–1267.CrossRefPubMedGoogle Scholar
  13. 13.
    Dominitz JA, Robertson DJ. Does flexible sigmoidoscopy reduce colorectal cancer incidence and mortality? Gastroenterol. 2009;137:1529–1531.CrossRefGoogle Scholar
  14. 14.
    Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the US preventative services task force. Annals Int Med. 2008;149:638–658.Google Scholar
  15. 15.
    Kato J, Morikawa T, Altamirano JT, et al. Combination of sigmoidoscopy and fecal immunochemical test to detect proximal colon neoplasia. Clin Gastroenterol Hepatol. 2009;7(12):1341–1346.CrossRefPubMedGoogle Scholar
  16. 16.
    Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Int Med. 2009;150:1–8.PubMedGoogle Scholar
  17. 17.
    Ransohoff DA. How much does colonoscopy reduce colon cancer mortality? Ann Int Med. 2009;150:50–52.PubMedGoogle Scholar

Copyright information

© US Government 2010

Authors and Affiliations

  1. 1.Raymond G. Murphy VA Medical Center–111FAlbuquerqueUSA
  2. 2.Division of Gastroenterology & HepatologyUniversity of New Mexico School of MedicineAlbuquerqueUSA

Personalised recommendations